Works matching IS 11738804 AND DT 2020 AND VI 34 AND IP 5

Results: 11

Changes in Anthropometric Parameters After Anti-TNFα Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

Published in:

BioDrugs, 2020, v. 34, n. 5, p. 649, doi. 10.1007/s40259-020-00444-9

By:

Mazhar, Faizan;
Battini, Vera;
Pozzi, Marco;
Invernizzi, Elena;
Mosini, Giulia;
Gringeri, Michele;
Capuano, Annalisa;
Scavone, Cristina;
Radice, Sonia;
Clementi, Emilio;
Carnovale, Carla

Publication type:

Article

PF-06410293: An Adalimumab Biosimilar.

Published in:

BioDrugs, 2020, v. 34, n. 5, p. 695, doi. 10.1007/s40259-020-00445-8

By:

Lee, Arnold;
Shirley, Matt

Publication type:

Article

Monoclonal Antibody-Based Therapies for Myasthenia Gravis.

Published in:

BioDrugs, 2020, v. 34, n. 5, p. 557, doi. 10.1007/s40259-020-00443-w

By:

Alabbad, Sawsan;
AlGaeed, Mohanad;
Sikorski, Patricia;
Kaminski, Henry J.

Publication type:

Article

Immunotherapy in Breast Cancer: Current Practice and Clinical Challenges.

Published in:

BioDrugs, 2020, v. 34, n. 5, p. 611, doi. 10.1007/s40259-020-00436-9

By:

de Melo Gagliato, Debora;
Buzaid, Antonio C.;
Perez-Garcia, Jose;
Cortes, Javier

Publication type:

Article

Drug Survival of Biologics in Treating Ankylosing Spondylitis: A Systematic Review and Meta-analysis of Real-World Evidence.

Published in:

BioDrugs, 2020, v. 34, n. 5, p. 669, doi. 10.1007/s40259-020-00442-x

By:

Yu, Chia-Ling;
Yang, Chung-Han;
Chi, Ching-Chi

Publication type:

Article

Cell Therapy for Idiopathic Pulmonary Fibrosis: Rationale and Progress to Date.

Published in:

BioDrugs, 2020, v. 34, n. 5, p. 543, doi. 10.1007/s40259-020-00437-8

By:

Ntolios, Paschalis;
Steiropoulos, Paschalis;
Karpathiou, Georgia;
Anevlavis, Stavros;
Karampitsakos, Theodoros;
Bouros, Evangelos;
Froudarakis, Marios E.;
Bouros, Demosthenes;
Tzouvelekis, Argyrios

Publication type:

Article

Designer Exosomes: A New Platform for Biotechnology Therapeutics.

Published in:

BioDrugs, 2020, v. 34, n. 5, p. 567, doi. 10.1007/s40259-020-00434-x

By:

Jafari, Davod;
Shajari, Samira;
Jafari, Rasool;
Mardi, Narges;
Gomari, Hosna;
Ganji, Fatemeh;
Forouzandeh Moghadam, Mehdi;
Samadikuchaksaraei, Ali

Publication type:

Article

Correction to: Assessment of Structural and Functional Comparability of Biosimilar Products: Trastuzumab as a Case Study.

Published in:

2020

By:

Joshi, Srishti;
Rathore, Anurag S.

Publication type:

Correction Notice

Innovative Therapies for Hemoglobin Disorders.

Published in:

BioDrugs, 2020, v. 34, n. 5, p. 625, doi. 10.1007/s40259-020-00439-6

By:

Sii-Felice, Karine;
Negre, Olivier;
Brendel, Christian;
Tubsuwan, Alisa;
Morel-à-l'Huissier, Eglantine;
Filardo, Camille;
Payen, Emmanuel

Publication type:

Article

Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials.

Published in:

BioDrugs, 2020, v. 34, n. 5, p. 681, doi. 10.1007/s40259-020-00438-7

By:

Jørgensen, Kristin K.;
Goll, Guro L.;
Sexton, Joe;
Bolstad, Nils;
Olsen, Inge C.;
Asak, Øivind;
Berset, Ingrid P.;
Blomgren, Ingrid M.;
Dvergsnes, Katrine;
Florholmen, Jon;
Frigstad, Svein O.;
Henriksen, Magne;
Hagfors, Jon;
Huppertz-Hauss, Gert;
Haavardsholm, Espen A.;
Klaasen, Rolf A.;
Moum, Bjørn;
Noraberg, Geir;
Prestegård, Ulf;
Rydning, Jan H.

Publication type:

Article

Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015–2020.

Published in:

BioDrugs, 2020, v. 34, n. 5, p. 587, doi. 10.1007/s40259-020-00435-w

By:

Rolfes, Leoni;
Pawlitzki, Marc;
Pfeuffer, Steffen;
Huntemann, Niklas;
Wiendl, Heinz;
Ruck, Tobias;
Meuth, Sven G.

Publication type:

Article